Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.3%

3 terminated/withdrawn out of 29 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

10%

3 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

N/A

14(51.9%)

Phase 1

5(18.5%)

Phase 3

3(11.1%)

Phase 2

3(11.1%)

Early Phase 1

2(7.4%)

27Total

N/A(14)

Phase 1(5)

Phase 3(3)

Phase 2(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (29)

Showing 20 of 29 trials

NCT03862911Not ApplicableActive Not Recruiting

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer

Role: collaborator

NCT05784428Not ApplicableRecruiting

Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Role: collaborator

NCT04990895Not ApplicableTerminated

A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys

Role: collaborator

NCT04677049Phase 1Suspended

Study of Niacin in Glioblastoma

Role: collaborator

NCT02984163Not ApplicableActive Not Recruiting

Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study

Role: collaborator

NCT05432518Early Phase 1Recruiting

Pilot Trial for Treatment of Recurrent Glioblastoma

Role: collaborator

NCT03391973Phase 2Active Not Recruiting

Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)

Role: collaborator

NCT04557501Phase 3Active Not Recruiting

PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer

Role: collaborator

NCT00956384Not ApplicableCompleted

One-stage Breast Reconstruction Using Dermal Matrix/Implant Versus Two-stage Expander/Implant Procedure

Role: collaborator

NCT02295722Phase 1Terminated

GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma

Role: collaborator

NCT04104945Not ApplicableRecruiting

p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)

Role: collaborator

NCT02801123Not ApplicableUnknown

The MATCH Study: Mindfulness And Tai Chi for Cancer Health

Role: collaborator

NCT04831190Not ApplicableUnknown

A Tailored Exercise Oncology Program for Neuro-Oncology Patients

Role: collaborator

NCT03617133Phase 2Recruiting

Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer

Role: collaborator

NCT01813370Completed

A Registry for Patients Treated on the Clinical Trial TAX 3503

Role: collaborator

NCT05136079Phase 3Unknown

Prophylactic LYMphatic Reconstruction (LYMbR) to Prevent Lymphedema After Node Dissection for Cutaneous Malignancies

Role: collaborator

NCT03396848Not ApplicableUnknown

Sexual Health and Rehabilitation eClinic (SHAReClinic)

Role: collaborator

NCT02834416Phase 3Completed

ADT Exercise Trial and Economic Analysis

Role: collaborator

NCT01654458Not ApplicableCompleted

A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer

Role: collaborator

NCT04575831Not ApplicableCompleted

Exercise, Nutrition, and Palliative Care in Advanced Lung Cancer (ENPAL)

Role: collaborator